| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Monia Brett P60 | Chief Executive Officer | Sell | 13,242 | $32.45 | $429,655.23 | -5.7% | -0.6% | +159.2% | |
| Jan 31, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sell | 1,523 | $32.44 | $49,403.68 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sell | 1,406 | $32.40 | $45,561.29 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 1,327 | $32.46 | $43,079.20 | -1.4% | -0.6% | +159.2% | |
| Jan 31, 2025 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sell | 1,484 | $32.20 | $47,779.90 | -2.4% | -0.6% | +159.2% | |
| Jan 16, 2025 | Swayze Eric63 | EVP Research | Sale+OE | 7,176 | $32.84 | $235,678.22 | -13.5% | -12.2% | +136.5% | |
| Jan 16, 2025 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 6,523 | $32.79 | $213,889.17 | -10.0% | -12.2% | +136.5% | |
| Jan 16, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 7,360 | $32.83 | $241,628.80 | -10.7% | -12.2% | +136.5% | |
| Jan 16, 2025 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 33,445 | $32.63 | $1,091,444.13 | -13.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 8,870 | $32.81 | $290,989.22 | -7.6% | -12.2% | +136.5% |